Compile Data Set for Download or QSAR
Report error Found 103 Enz. Inhib. hit(s) with all data for entry = 9514
TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472405(US10829483, Compound WX013)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472406(US10829483, Compound WX014)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472403(US10829483, Compound WX011)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472404(US10829483, Compound WX012)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472401(US10829483, Compound WX009)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472397(US10829483, Compound WX005)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472481(US10829483, Compound WX069)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472476(US10829483, Compound WX067)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472431(US10829483, Compound WX033)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472432(US10829483, Compound WX034)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472426(US10829483, Compound WX031)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472427(US10829483, Compound WX032)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472424(US10829483, Compound WX029)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472509(US10829483, Compound WX093)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472425(US10829483, Compound WX030)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472510(US10829483, Compound WX094)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472422(US10829483, Compound WX027)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472506(US10829483, Compound WX091)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472423(US10829483, Compound WX028)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472508(US10829483, Compound WX092)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472420(US10829483, Compound WX026)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472501(US10829483, Compound WX088)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472433(US10829483, Compound WX035)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472391(US10829483, Compound WX001)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472474(US10829483, Compound WX065)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472475(US10829483, Compound WX066)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472472(US10829483, Compound WX063)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472469(US10829483, Compound WX061)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472470(US10829483, Compound WX062)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472467(US10829483, Compound WX059)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472468(US10829483, Compound WX060)
Affinity DataIC50: 500nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472409(US10829483, Compound WX017)
Affinity DataIC50: 2.75E+3nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472494(US10829483, Compound WX081)
Affinity DataIC50: 2.75E+3nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472411(US10829483, Compound WX018)
Affinity DataIC50: 2.75E+3nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472492(US10829483, Compound WX079)
Affinity DataIC50: 2.75E+3nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472408(US10829483, Compound WX016)
Affinity DataIC50: 2.75E+3nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472493(US10829483, Compound WX080)
Affinity DataIC50: 2.75E+3nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472488(US10829483, Compound WX075)
Affinity DataIC50: 2.75E+3nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472489(US10829483, Compound WX076)
Affinity DataIC50: 2.75E+3nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472402(US10829483, Compound WX010)
Affinity DataIC50: 2.75E+3nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472399(US10829483, Compound WX007)
Affinity DataIC50: 2.75E+3nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472484(US10829483, Compound WX071)
Affinity DataIC50: 2.75E+3nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472400(US10829483, Compound WX008)
Affinity DataIC50: 2.75E+3nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472398(US10829483, Compound WX006)
Affinity DataIC50: 2.75E+3nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472483(US10829483, Compound WX070)
Affinity DataIC50: 2.75E+3nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472395(US10829483, Compound WX003)
Affinity DataIC50: 2.75E+3nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472396(US10829483, Compound WX004)
Affinity DataIC50: 2.75E+3nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472479(US10829483, Compound WX068)
Affinity DataIC50: 2.75E+3nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472502(US10829483, Compound WX089)
Affinity DataIC50: 2.75E+3nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetSolute carrier family 22 member 12(Human)
Cstone Pharmaceutical (Suzhou)

US Patent
LigandPNGBDBM472503(US10829483, Compound WX090)
Affinity DataIC50: 2.75E+3nMAssay Description:Experimental Purpose:Determination of the IC50 value of the inhibitory activity of the compound against uric acid reabsorption by the HEK293 cell lin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

Displayed 1 to 50 (of 103 total ) | Next | Last >>
Jump to: